Silymarin: A Review of its Clinical Properties in the Management of Hepatic Disorders
Top Cited Papers
- 1 January 2001
- journal article
- review article
- Published by Springer Nature in BioDrugs
- Vol. 15 (7) , 465-489
- https://doi.org/10.2165/00063030-200115070-00005
Abstract
The mechanisms of action of silymarin involve different biochemical events, such as the stimulation of the synthetic rate of ribosomal RNA (rRNA) species through stimulation of polymerase I...Keywords
This publication has 33 references indexed in Scilit:
- Silymarin: What is in the name …? An appeal for a change of editorial policyHepatology, 2000
- Herbal products for liver diseases: A therapeutic challenge for the new millenniumHepatology, 1999
- Skin Cancer Chemopreventive Effects of a Flavonoid Antioxidant Silymarin Are Mediated via Impairment of Receptor Tyrosine Kinase Signaling and Perturbation in Cell Cycle ProgressionBiochemical and Biophysical Research Communications, 1998
- Milk Thistle ( Silybum marianum ) for the Therapy of Liver DiseaseAmerican Journal of Gastroenterology, 1998
- Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibininHepatology, 1996
- Scavenging of reactive oxygen species and inhibition of arachidonic acid metabolism by silibinin in human cellsLife Sciences, 1996
- Acetaminophen-lnduced Toxicity to Human Epidermoid Cell Line A431 and Hepatoblastoma Cell Line Hep G2, in vitro. Is Diminished by SilymarinSkin Pharmacology and Physiology, 1995
- Hepatoprotective mechanism of silymarin: No evidence for involvement of cytochrome P450 2E1Chemico-Biological Interactions, 1994
- Silymarin and Its Components Are Inhibitors of .BETA.-Glucuronidase.Biological & Pharmaceutical Bulletin, 1994
- Effects of silybin on histamine release from human basophil leucocytes.British Journal of Clinical Pharmacology, 1987